Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis

Apoptosis

Volumn 11, Issue 10, 2006, Pages 1661-1675

  Kutuk, Ozgur ^a   Basaga, Huveyda ^a  

^a SABANCI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Atherosclerosis; Bcl 2; Inflammation; Oxidation

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; CASPASE 3; CASPASE 7; CASPASE 8; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL STRUCTURE; CHROMATIN CONDENSATION; CYTOPLASM; DNA CLEAVAGE; HUMAN; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; DNA DAMAGE; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; MULTIGENE FAMILY; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 33748573684     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-9402-7     Document Type: Review

References (141)

1. Littlewood TD, Bennett MR (2003) Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14:469-475
2. Morissette MR, Rosenzweig A (2005) Targeting survival signaling in heart failure. Curr Opin Pharmacol 5:165-170
3. Hajra KM, Liu JR (2004) Apoptosome dysfunction in human cancer. Apoptosis 9:691-704
4. Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581-589
5. Dickson DW (2004) Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J Clin Invest 2004; 114:23-27
6. Heiser D, Labi V, Erlacher M, Villunger A. The Bcl-2 protein family and its role in the development of neoplastic disease. Exp Gerontol 39:1125-1135
7. Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693s-1700s
8. Bakhshi A, Wright JJ, Graninger W, et al (1987) Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84:2396-2400
9. Ottilie S, Diaz JL, Horne W, et al (1997) Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem 272:30866-30872
10. Hsu SY, Kaipia A, McGee E, et al (1997) Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci USA 94:12401-12406
11. Rashmi R, Kumar S, Karunagaran D (2005) Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26:713-723
12. Shibue T, Takeda K, Oda E, et al (2003) Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17:2233-2238
13. Wang K, Yin XM, Chao DT, et al (1996) BID: a novel BH3 domain-only death agonist. Genes Dev 10:2859-2869
14. Strasser A, O'Connor L, Dixit VM (2000) Apoptosis signaling. Annu Rev Biochem 69:217-245
15. Lee T, Chau L (2001) Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 280:C709-C718
16. Vicca S, Massy ZA, Hennequin C, et al (2003) Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid. Free Radic Biol Med 35:603-615
17. Norata GD, Tonti L, Roma P, Catapano AL (2002) Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis 12:297-305
18. Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157:1415-1430
19. Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615-647
20. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305-1308
21. Sun XM, MacFarlane M, Zhuang J, et al (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274:5053-5060
22. Sprick MR, Weigand MA, Rieser E, et al (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599-609
23. Bodmer JL, Holler N, Reynard S, et al (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2:241-243
24. Soderstrom TS, Poukkula M, Holmstrom TH, et al (2002) Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. J Immunol 169:2851-2860
25. Scaffidi C, Fulda S, Srinivasan A, et al (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675-1687
26. Ochs K, Kaina B (2000) Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res 60:5815-5824
27. Slee EA, Keogh SA, Martin SJ (2000) Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome crelease. Cell Death Differ 7:556-565
28. de Moissac D, Gurevich RM, Zheng H, et al (2000) Caspase activation and mitochondrial cytochrome crelease during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 32:53-63
29. Neame SJ, Rubin LL, Philpott KL (1998) Blocking cytochrome cactivity within intact neurons inhibits apoptosis. J Cell Biol 142:1583-1593
30. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome cfrom mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
31. Adrain C, Creagh EM, Martin SJ (2001) Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20:6627-6636
32. van Loo G, van Gurp M, Depuydt B, et al (2002) The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 9:20-26
33. van Loo G, Saelens X, van Gurp M, et al (2002) The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9:1031-1042
34. Zhang W, Li D, Mehta JL (2004) Role of AIF in human coronary artery endothelial cell apoptosis. Am J Physiol Heart Circ Physiol 286:H354-H358
35. Sakurai K, Katoh M, Fujimoto Y (2001) Alloxan-induced mitochondrial permeability transition triggered by calcium, thiol oxidation, and matrix ATP. J Biol Chem 276:26942-26946
36. Gottlieb RA (2000) Mitochondria: execution central. FEBS Lett 482:6-12
37. Petronilli V, Miotto G, Canton M, et al (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76:725-734
38. Petronilli V, Penzo D, Scorrano L, et al (2001) The mitochondrial permeability transition, release of cytochrome cand cell death. Correlation with the duration of pore openings in situ. J Biol Chem 276:12030-12034
39. Marzo I, Brenner C, Zamzami N, et al (1998) The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 187:1261-1271
40. Shimizu S, Narita M, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome cby the mitochondrial channel VDAC. Nature 399:483-487
41. Marzo I, Brenner C, Zamzami N, et al (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027-2031
42. Belzacq AS, Vieira HL, Verrier F, et al (2003) Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 63:541-546
43. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, et al (1999) Bax-induced caspase activation and apoptosis via cytochrome crelease from mitochondria is inhibitable by Bcl-xL. J Biol Chem 274:2225-2233
44. Narita M, Shimizu S, Ito T, et al (1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome crelease in isolated mitochondria. Proc Natl Acad Sci USA 95:14681-14686
45. Antonsson B, Montessuit S, Sanchez B, Martinou JC (2001) Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276:11615-11623
46. Nouraini S, Six E, Matsuyama S, et al (2000) The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L). Mol Cell Biol 20:1604-1615
47. Mikhailov V, Mikhailova M, Degenhardt K, et al (2003) Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome crelease. J Biol Chem 278:5367-5376
48. Mikhailov V, Mikhailova M, Pulkrabek DJ, et al (2001) Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 276:18361-18374
49. Schendel SL, Xie Z, Montal MO, et al (1997) Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 94:5113-5118
50. Nechushtan A, Smith CL, Hsu YT, Youle RJ (1999) Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 18:2330-2341
51. Schinzel A, Kaufmann T, Borner c(2004) Bcl-2 family members: integrators of survival and death signals in physiology and pathology. Biochim Biophys Acta 1644:95-105
52. Nguyen M, Millar DG, Yong VW, et al (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem 268:25265-25268
53. del Mar Martinez-Senac M, Corbalan-Garcia S, Gomez-Fernandez JC (2000) Study of the secondary structure of the C-terminal domain of the antiapoptotic protein bcl-2 and its interactionwith modelmembranes. Biochemistry 39:7744-7752
54. Aritomi M, Kunishima N, Inohara N, et al (1997) Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family. J Biol Chem 272:27886-27892
55. Muchmore SW, Sattler M, Liang H, et al (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335-341
56. Huang Q, Petros AM, Virgin HW, et al (2002) Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci USA 99:3428-3433
57. Sattler M, Liang H, Nettesheim D, et al (1997) Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275:983-986
58. Korsmeyer SJ, Gross A, Harada H, et al (1999) Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. Cold Spring Harb Symp Quant Biol 64:343-350
59. Gilmore AP, Metcalfe AD, Romer LH, Streuli CH (2000) Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol 149:431-446
60. Desagher S, Osen-Sand A, Nichols A, et al (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome crelease during apoptosis. J Cell Biol 144:891-901
61. He H, Lam M, McCormick TS, Distelhorst CW (1997) Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 138:1219-1228
62. Bruce-Keller AJ, Begley JG, Fu W, et al (1998) Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J Neurochem 70:31-39
63. Bogdanov MB, Ferrante RJ, Mueller G, et al (1999) Oxidative stress is attenuated in mice overexpressing BCL-2. Neurosci Lett 262:33-36
64. Yang J, Liu X, Bhalla K, et al (1997) Prevention of apoptosis by Bcl-2: release of cytochrome cfrom mitochondria blocked. Science 275:1129-1132
65. Mirkovic N, Voehringer DW, Story MD, et al (1997) Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene 15:1461-1470
66. Decaudin D, Geley S, Hirsch T, et al (1997) Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 57:62-67
67. Rokhlin OW, Guseva N, Tagiyev A, et al (2001) Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis. Oncogene 20:2836-2843
68. Sinicrope FA, Penington RC, Tang XM (2004) Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells. Clin Cancer Res 10:8284-8292
69. Memon SA, Moreno MB, Petrak D, Zacharchuk CM (1995) Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol 155:4644-4652
70. Gazitt Y, Shaughnessy P, Montgomery W (1999) Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2. Cytokine 11:1010-1019
71. Keogh SA, Walczak H, Bouchier-Hayes L, Martin SJ (2000) Failure of Bcl-2 to block cytochrome credistribution during TRAIL-induced apoptosis. FEBS Lett 471:93-98
72. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240
73. Motoyama N, Wang F, Roth KA, et al (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506-1510
74. Conus S, Rosse T, Borner c(2000) Failure of Bcl-2 family members to interact with Apaf-1 in normal and apoptotic cells. Cell Death Differ 7:947-954
75. Murphy KM, Streips UN, Lock RB (2000) Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation. J Biol Chem 275:17225-17228
76. He L, Perkins GA, Poblenz AT, et al (2003) Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice. Proc Natl Acad Sci USA 100:1022-1027
77. Ruffolo SC, Shore GC (2003) BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J Biol Chem 278:25039-25045
78. Willis SN, Chen L, Dewson G, et al (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305
79. Ito T, Deng X, Carr B, May WS (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671-11673
80. Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19:8469-8478
81. Basu A, Haldar S (2003) Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Lett 538:41-47
82. Fadeel B, Hassan Z, Hellstrom-Lindberg E, et al (1999) Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia 13:719-728
83. Liang Y, Nylander KD, Yan C, Schor NF (2002) Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2. Mol Pharmacol 61:142-149
84. Cheng EH, Kirsch DG, Clem RJ, et al (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966-1968
85. Kirsch DG, Doseff A, Chau BN, et al (1999) Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274:21155-21161
86. Basanez G, Zhang J, Chau BN, et al (2001) Pro-apoptotic cleavage products of Bcl-xL form cytochrome c-conducting pores in pure lipid membranes. J Biol Chem 276:31083-31091
87. Nechushtan A, Smith CL, Hsu YT, Youle RJ (1999) Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 18:2330-2341
88. Griffiths GJ, Dubrez L, Morgan CP, et al (1999) Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol 144:903-914
89. Mandic A, Viktorsson K, Strandberg L, et al (2002) Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 22:3003-3013
90. Wei MC, Zong WX, Cheng EH, et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730
91. Deng Y, Lin Y, Wu X (2002) TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33-45
92. Han J, Goldstein LA, Gastman BR, et al (2004) Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells. Leukemia 18:1671-1680
93. Ruiz-Vela A, Opferman JT, Cheng EH, Korsmeyer SJ (2005) Proapoptotic BAX and BAK control multiple initiator caspases. EMBO Rep 6:379-385
94. Wood DE, Thomas A, Devi LA, et al (1998) Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17:1069-1078
95. Cao X, Deng X, May WS (2003) Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102:2605-2614
96. Letai A (2003) BH3 domains as BCL-2 inhibitors: prototype cancer therapeutics. Expert Opin Biol Ther 3:293-304
97. Datta SR, Dudek H, Tao X, et al (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241
98. Datta SR, Katsov A, Hu L, et al (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6:41-51
99. Konishi Y, Lehtinen M, Donovan N, Bonni A (2002) Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell 9:1005-1016
100. Donovan N, Becker EB, Konishi Y, Bonni A (2002) JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 277:40944-40949
101. Dramsi S, Scheid MP, Maiti A, et al (2002) Identification of a novel phosphorylation site, Ser-170, as a regulator of bad pro-apoptotic activity. J Biol Chem 277:6399-6405
102. Putcha GV, Le S, Frank S, et al (2003) JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38:899-914
103. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694
104. Oda E, Ohki R, Murasawa H, et al (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058
105. Yu J, Zhang L, Hwang PM, et al (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7:673-682
106. Yu J, Wang Z, Kinzler KW, et al (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931-1936
107. Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501
108. Gross A, Yin XM, Wang K, et al (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome crelease, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156-1163
109. Zha J, Weiler S, Oh KJ, et al (2000) Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290:1761-1765
110. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
111. Kutuk O, Basaga H (2003) Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 9:549-557
112. Masuda J, Ross R (1990) Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis 10:164-177
113. Pauletto P, Sartore S, Pessina AC (1994) Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin Sci 87:467-479
114. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
115. Alvarez RJ, Gips SJ, Moldovan N, et al (1997) 17beta-estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Commun 237:372-381
116. Bennett MR, Evan GI, Schwartz SM (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 95:2266-2274
117. Soldani C, Scovassi AI, Canosi U, et al (2005) Multicolor fluorescence technique to detect apoptotic cells in advanced coronary atherosclerotic plaques. Eur J Histochem 49:47-52
118. Lee HS, Chang JS, Baek JA, et al (2005) TNF-alpha activates death pathway in human aorta smooth muscle cell in the presence of 7-ketocholesterol. Biochem Biophys Res Commun 333:1093-1099
119. Michowitz Y, Goldstein E, Roth A, et al (2005) The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol 45:1018-1024
120. Takarada S, Imanishi T, Hano T, Nishio I (2003) Oxidized low-density lipoprotein sensitizes human vascular smooth muscle cells to FAS (CD95)-mediated apoptosis. Clin Exp Pharmacol Physiol 30:289-294
121. Kockx MM, De Meyer GR, Muhring J, et al (1998) Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97:2307-2315
122. Saxena A, McMeekin JD, Thomson DJ (2002) Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens. J Pathol 196:335-342
123. Pollman MJ, Hall JL, Mann MJ, et al (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 4:222-227
124. Krajewski S, Krajewska M, Shabaik A, et al (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323-1336
125. Molostvov G, Morris A, Rose P, Basu S (2002) Modulation of Bcl-2 family proteins in primary endothelial cells during apoptosis. Pathophysiol Haemost Thromb 32:85-91
126. Messmer UK, Briner VA, Pfeilschifter J (1999) Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55:2322-2337
127. Badrichani AZ, Stroka DM, Bilbao G, et al (1999) Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest 103:543-553
128. Ackermann EJ, Taylor JK, Narayana R, Bennett CF (1999) The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J Biol Chem 274:11245-11252
129. Grethe S, Ares MP, Andersson T, Porn-Ares MI (2004) p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp Cell Res 298:632-642
130. Kim HH, Kim K (2003) Enhancement of TNF-alpha-mediated cell death in vascular smooth muscle cells through cytochrome c-independent pathway by the proteasome inhibitor. FEBS Lett 535:190-194
131. Sata M, Walsh K (1998) Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J Clin Invest 102:1682-1689
132. Sata M, Suhara T, Walsh K (2000) Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. Arterioscler Thromb Vasc Biol 20:309-316
133. Chen J, Mehta JL, Haider N, et al (2004) Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94:370-376
134. Vicca S, Massy ZA, Hennequin C, et al (2003) Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid. Free Radic Biol Med 35:603-615
135. Kataoka H, Kume N, Miyamoto S, et al (2001) Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:955-960
136. Yao PM, Tabas I (2001) Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 276:42468-42476
137. Liu J, Thewke DP, Su YR, et al (2005) Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 25:174-179
138. Rusinol AE, Thewke D, Liu J, et al (2004) AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem 279:1392-1399
139. Napoli C, Quehenberger O, De Nigris F, et al (2000) Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 14:1996-2007
140. Meilhac O, Escargueil-Blanc I, Thiers JC, et al (1999) Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J 13:485-494
141. Hufnagel B, Dworak M, Soufi M, et al (2005) Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells. Atherosclerosis. 180:245-254